Volume 97, Issue 2 pp. 187-192

Varicella-related deaths in children and adolescents – Germany 2003–2004

Veit Grote

Veit Grote

Institute of Social Pediatrics and Adolescent Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for more papers by this author
Rüdiger Von Kries

Rüdiger Von Kries

Institute of Social Pediatrics and Adolescent Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for more papers by this author
Wolfgang Springer

Wolfgang Springer

Department of Pediatric Cardiology, University of Heidelberg, Heidelberg, Germany

Search for more papers by this author
Gerhard Hammersen

Gerhard Hammersen

CNOPF Children's Hospital, Nuremberg, Germany

Search for more papers by this author
Hans Wolfgang Kreth

Hans Wolfgang Kreth

Pediatric Hospital, University of Wurzburg, Wurzburg, Germany

Search for more papers by this author
Johannes Liese

Johannes Liese

Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for more papers by this author
First published: 11 December 2007
Citations: 30
Correspondence
Dr. Veit Grote, M.Sc., Institute of Social Paediatrics and Adolescent Medicine, Ludwig-Maximilian University, Heiglhofstr. 63, 81377 Munich, Germany. Tel: +49-89-71009-307 | Fax: +49-89-71009-315 | Email: [email protected]

Abstract

Aim: Although varicella is acknowledged as a rare cause of death in children, there are few comprehensive data with respect to the clinical course leading to death.

Methods: A nationwide, active surveillance was carried out in Germany for children up to age 17 years who were admitted to a paediatric hospital for varicella or associated complications, including deaths.

Results: A total of 10 children with varicella-associated death were reported over period of 2 years, yielding a mortality rate of 0.4/1 000 000 children per year. Three deaths occurred in children diagnosed with acute lymphocytic leukaemia and disseminated varicella, two shortly after diagnosis of leukaemia and therefore not preventable, and one during remission with an untypical presentation. Two children died with a congenital varicella syndrome. There was no death in children with neonatal varicella. Four other cases were related to varicella pneumonia or septicaemia and one to myocarditis.

Conclusion: In a population with no general varicella vaccination programme, varicella accounted for a small but not negligible risk for death in immunocompetent and immunocompromised children. Together these data point to the importance of a thoroughly implemented, general varicella vaccination programme.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.